Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:moderna [2022/08/28 17:38]
pamela [Company Linked to CIA Now Making mRNA for Moderna’s Reformulated COVID Booster Shots]
+++ pharmaceutical_companies:moderna [2024/05/01 18:33] (current)
liam
@@ Line 1: / Line 1: @@
 ====== Moderna ======
-{{ :pharmaceutical_companies:modernalogo.png?200|}}
+{{ :pharmaceutical_companies:moderna_logo_.png?200|}}
 **Moderna, Inc.** is an American [[:pharmaceutical_companies|pharmaceutical]] and [[:biotechnology]] company based in [[:united_states_of_america:massachusetts:Cambridge]], [[:united_states_of_America:Massachusetts]].
+===== History =====
+Moderna began collaborating with [[alexion|Alexion Pharmaceuticals]] in January 2014, entering an agreement for ten product options based on Moderna's mRNA platform.((//Elpidera.// (2016). Moderna Therapeutics. https://archive.ph/uennQ)) ((Reidy, C. (2014, January 13). //Alexion, Moderna announce agreement to develop messenger RNA therapeutics.// Boston Globe Media Partners. https://web.archive.org/web/20230605072835/https://www.boston.com/news/innovation/2014/01/13/alexion-moderna-announce-agreement-to-develop-messenger-rna-therapeutics/)) On January 14, 2014, Moderna announced the creation of [[Onkaido Therapeutics]] to focus "exclusively on developing mRNA-based [[:oncology]] treatments."((Favorito, M. (2014, January 14). //Moderna Launches Onkaido Therapeutics to Focus on the Development of mRNA TherapeuticsTM in Oncology with $20 Million Capital Commitment.// Moderna Therapeutics. http://archive.today/2016.11.20-035524/http://www.modernatx.com/news-events/press-releases/moderna-launches-onkaido-therapeutics-focus-development-mrna-therapeuticstm)) ((Gormley, B. (2014, January 15). //Moderna Launches Cancer Drug Co. Onkaido Therapeutics With $20M Investment.// Wall Street Journal. http://archive.today/2023.06.05-073743/https://www.wsj.com/amp/articles/DJFVW00020140114ea1eqwhzn))
+On January 8, 2015, Moderna announced the launch of its second spinoff company, Valera, "focused exclusively on the advancement of vaccines and therapeutics for the prevention and treatment of viral, bacterial and parasitic infectious diseases."[5]
+On May 12, 2015, Moderna announced the launch of its third spinoff company, Elpidera, intended to "advance novel messenger RNA therapies" while continuing Moderna's work with Alexion.[6]
+On October 22, 2015, Moderna announced the launch of its fourth spinoff company, [[Caperna]], intended to "focus exclusively on the advancement of personalized [[:cancer vaccines]]."((Melone, L. (2015, October 22). //Moderna Launches Caperna LLC, Its Fourth Venture, to Develop Personalized Cancer Vaccines.// Moderna Therapeutics. https://web.archive.org/web/20161119220026/http://www.modernatx.com/news-events/press-releases/moderna-launches-caperna-llc-its-fourth-venture-develop-personalized-cancer)) Caperna's work involved collaborations with [[Merck]].((//Caperna LLC.// (2016). Moderna Therapeutics. https://web.archive.org/web/20161029183424/http://www.modernatx.com/our-business-model/ventures/caperna-llc))
+On January 12, 2016, Moderna announced that it had entered a funding agreement with the [[:Bill & Melinda Gates Foundation]] to develop therapeutics against [[:HIV]] and other diseases. The agreement included an initial $20 million grant, with the potential to increase the amount to $100 million.((//Bill & Melinda Gates Foundation — Advancing an mRNA-based antibody combination to help prevent HIV infection.// Moderna. Retrieved March 21, 2022, from http://archive.today/2021.08.23-023928/https://www.modernatx.com/ecosystem/strategic-collaborators/foundations-advancing-mrna-science-and-research)) ((//Moderna Wins Initial $20M Grant from Gates Foundation.// (2016, January 12). GEN - Genetic Engineering and Biotechnology News. http://archive.today/2023.02.03-040340/https://www.genengnews.com/topics/omics/moderna-wins-initial-20m-grant-from-gates-foundation/))
 ===== Organization =====
@@ Line 11: / Line 23: @@
 In addition to its core business, Moderna spun out several venture firms to focus on different applications of their [[:mRNA]] delivery technology.
-  * [[Caperna]] focused exclusively on the advancement of personalized [[cancer vaccines]].((//Caperna LLC.// (2016). Moderna Therapeutics. https://web.archive.org/web/20161029183424/http://www.modernatx.com/our-business-model/ventures/caperna-llc))
+  * [[Caperna]] focused exclusively on the advancement of personalized [[:cancer vaccines]].((//Caperna LLC.// (2016). Moderna Therapeutics. https://web.archive.org/web/20161029183424/http://www.modernatx.com/our-business-model/ventures/caperna-llc))
   * [[Elpidera]] was formed to develop mRNA-based medicines to treat rare diseases.((//Elpidera.// (2016). Moderna Therapeutics. https://archive.ph/uennQ))
   * [[Onkaido Therapeutics]] was focused exclusively on the advancement of [[:oncology]] products for previously "undruggable" targets.((//mRNA-based Oncology Treatments.// Onkaido Therapeutics. Retrieved October 12, 2016, from https://web.archive.org/web/20161012181337/http://onkaido.com/about/))
@@ Line 204: / Line 216: @@
 {{:pharmaceutical_companies:moderna_sponsor_us_open.png?800|}}
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/Moderna|White Rose Wiki]]
+  * [[https://wikispooks.com/wiki/Moderna|Wikispooks]]